Ramanatha Saralaya
Ramanatha Saralaya publishes mostly in Molecular Biology, Cellular and Molecular Neuroscience and Infectious Diseases, on topics such as Tuberculosis Research and Epidemiology, Neuroscience and Neuropharmacology Research and Neurotransmitter Receptor Influence on Behavior.
- World rank
- #2,115,494 of 7,710,434 ranked researchers
- Rank in India
- #37,267 of 280,097
- Works
- 33
- Citations
- 885
- Citations per work
- 26.8
What does Ramanatha Saralaya research?
Ramanatha Saralaya's work is mostly in Medicine (28%), Biochemistry, Genetics and Molecular Biology (22%), Neuroscience (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1235.8%
- Everything else1235.8%
- Health Sciences928.4%
- Medicine928.4%
- 1Molecular Biology22% of their works
- 2Cellular and Molecular Neuroscience14% of their works
- 3Infectious Diseases14% of their works
- 4Pharmacology6% of their works
- 5Public Health, Environmental and Occupational Health4% of their works
- 6Psychiatry and Mental health4% of their works
Research topics
- Tuberculosis Research and Epidemiology
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
- Receptor Mechanisms and Signaling
- Cancer therapeutics and mechanisms
- HIV/AIDS drug development and treatment
- Cholinesterase and Neurodegenerative Diseases
- Nicotinic Acetylcholine Receptors Study
Which keywords describe Ramanatha Saralaya's research?
The keywords of their largest research topics: Drug Resistance, Mycobacterium tuberculosis, Pharmacology, Tuberculosis, Alzheimer's Disease, Crystal Structure, Neurotransmission and Synaptic Plasticity.
- Nicotinic Acetylcholine Receptors
- Topoisomerases
- HIV Infection
- DNA
- Antiretroviral Therapy
- Serotonin
- Synaptic Plasticity
- Crystal Structure
- Tuberculosis
- Mycobacterium tuberculosis
- Drug Resistance
- Pharmacology
- Alzheimer's Disease
- Neurotransmission
- Dopamine
- Acetylcholinesterase
- Cholinesterase Inhibitors
- G-Protein-Coupled Receptors
- Signal Transduction
- Neuronal Signaling
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Drug Resistance122 topics
- Mycobacterium tuberculosis81 topic
- Pharmacology82 topics
- Tuberculosis81 topic
- Alzheimer's Disease72 topics
- Crystal Structure72 topics
- Neurotransmission71 topic
- Synaptic Plasticity71 topic
- Dopamine51 topic
- Serotonin51 topic
- Acetylcholinesterase41 topic
- Antiretroviral Therapy41 topic
- Cholinesterase Inhibitors41 topic
- DNA41 topic
- G-Protein-Coupled Receptors41 topic
- HIV Infection41 topic
- Signal Transduction41 topic
- Topoisomerases41 topic
- Neuronal Signaling31 topic
- Nicotinic Acetylcholine Receptors31 topic
Where does Ramanatha Saralaya work?
Ramanatha Saralaya's main affiliation in the publication record is Suven Life Sciences (India), India.
How many publications and citations does Ramanatha Saralaya have?
OpenAlex counts 33 works and 885 citations for Ramanatha Saralaya, an h-index of 13, ranking #2,115,494 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ramanatha Saralaya. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.